patient outcomes

Distribution and subacute modulation of endocannabinoid metabolizing enzymes in the trigeminal complex and midbrain in a pre-clinical model of post-traumatic headache

Study Overview The research focuses on the role of endocannabinoid metabolizing enzymes within the trigeminal complex and midbrain areas, particularly

Distribution and subacute modulation of endocannabinoid metabolizing enzymes in the trigeminal complex and midbrain in a pre-clinical model of post-traumatic headache Read Post »

Mechanisms underlying DEHP/MEHP-induced toxicity in multiple sclerosis: An integrated analysis combining network toxicology, bioinformatics, and in vivo experimental validation

Mechanisms of DEHP/MEHP Toxicity Di(2-ethylhexyl) phthalate (DEHP) and its primary metabolite, mono(2-ethylhexyl) phthalate (MEHP), are environmental pollutants commonly found in

Mechanisms underlying DEHP/MEHP-induced toxicity in multiple sclerosis: An integrated analysis combining network toxicology, bioinformatics, and in vivo experimental validation Read Post »

Myelin Oligodendrocyte Glycoprotein (MOG) Antibodies in the Cerebrospinal Fluid of Pediatric Patients With MOG Antibody-Associated Disease: Insights From an Asian Multicenter Cohort

Study Overview In recent years, the understanding of autoimmune conditions affecting the central nervous system has advanced, highlighting the role

Myelin Oligodendrocyte Glycoprotein (MOG) Antibodies in the Cerebrospinal Fluid of Pediatric Patients With MOG Antibody-Associated Disease: Insights From an Asian Multicenter Cohort Read Post »

Scroll to Top